TREVI THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.78 USD | +9.45% |
|
-1.94% | +107.46% |
| 03-20 | Transcript : Trevi Therapeutics, Inc., Q4 2023 Earnings Call, Mar 20, 2024 | |
| 03-20 | Trevi Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Trevi Therapeutics, Inc.
18e0a8d2afce1dac4572.M5Mp6FEj3I9oa7iS_sON1hA4tKnK1GMt5hKxwTU9qGY.QqtLsGFHpNYsHo39lqnlrE9C2Pn6ly1v03bJhV4KwQVwxBy-ExSp6DcB8Q~5e04c61e81dcb0bbfdcd146581e498ab
Upcoming events on Trevi Therapeutics, Inc.
Past events on Trevi Therapeutics, Inc.
| 25/04/2024 | European Pulmonary Fibrosis Patient Summit |
| 08/04/2024 18:30 | Needham Healthcare Conference |
| 20/03/2024 20:30 | Q4 2023 Earnings Call |
| 20/03/2024 20:05 | Q4 2023 Earnings Release |
| 17/03/2024 | BioEurope Spring Conference |
| 10/03/2024 | Leerink Partners Global Biopharma Conference |
| 07/03/2024 18:30 | Connecticut Rare Disease Forum |
| 05/03/2024 19:50 | TD Cowen Health Care Conference |
| 14/02/2024 15:00 | Oppenheimer Healthcare Life Sciences Conference |
| 07/01/2024 | LifeSci Partners Corporate Access Event |
| 13/11/2023 | Stifel Healthcare Conference |
| 09/11/2023 21:30 | Q3 2023 Earnings Call |
| 09/11/2023 21:05 | Q3 2023 Earnings Release |
| 12/10/2023 | European Academy of Dermatology and Venereology Conference |
| 26/09/2023 21:55 | Cantor Global Healthcare Conference |
| 26/09/2023 21:55 | Cantor Global Healthcare Conference |
| 19/09/2023 | SVB Securities Biopharma Summit |
| 08/09/2023 | European Respiratory Society International Congress |
| 16/08/2023 15:00 | Stifel Biotech Executive Summit |
| 10/08/2023 21:30 | Q2 2023 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -26,6 -28,0 4.98% | -32,4 -31,8 -2.08% | -32,4 -31,6 -2.69% | -29,9 -31,8 5.85% | -33,8 -34,7 2.57% | -44,6 |
|
EBIT Million USD | Released Forecast Spread | -26,6 -28,9 7.95% | -32,5 -31,5 -3.29% | -32,5 -32,3 -0.58% | -29,9 -31,9 6.1% | -33,9 -34,8 2.44% | -42,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -26,1 -27,4 4.86% | -32,8 -31,4 -4.55% | -34,0 -34,2 0.7% | -29,2 -32,5 10.05% | -29,1 -30,2 3.76% | -39,6 |
|
Net income Million USD | Released Forecast Spread | -26,8 -27,4 2.36% | -32,8 -31,4 -4.49% | -33,9 -34,2 0.76% | -29,2 -32,2 9.37% | -29,1 -30,1 3.52% | -41,1 |
|
EPS USD | Released Forecast Spread | -2,28 -1,91 -19.37% | -1,81 -1,73 -4.62% | -1,49 -1,44 -3.47% | -0,45 -0,51 11.18% | -0,29 -0,31 4.92% | -0,39 |
| Announcement Date | 16/03/20 | 25/03/21 | 17/03/22 | 16/03/23 | 20/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -8,26 -7,38 -12% | -7,01 -9,10 22.92% | -7,81 -9,70 19.46% | -8,40 -10,6 20.79% | -6,61 -8,50 22.19% | -7,54 -8,30 9.11% | -8,38 -8,75 4.21% | -9,01 -10,0 9.9% | -8,90 -9,70 8.27% | -10,2 | -10,8 | -11,7 | -11,9 |
|
EBIT Million USD | Released Forecast Spread | -8,27 -8,09 -2.28% | -7,03 -8,54 17.74% | -7,82 -8,22 4.83% | -8,41 -8,57 1.91% | -6,66 -8,57 22.29% | -7,56 -7,80 3.04% | -8,38 -9,26 9.51% | -9,05 -9,25 2.22% | -8,93 -9,80 8.85% | -9,75 | -10,4 | -11,0 | -11,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,53 -8,80 3.11% | -7,33 -8,41 12.79% | -8,06 -7,92 -1.67% | -8,27 -8,09 -2.25% | -5,53 -8,75 36.86% | -6,41 -7,27 11.82% | -7,18 -9,03 20.57% | -7,71 -8,60 10.34% | -7,80 -8,97 12.98% | -8,77 | -9,37 | -9,87 | -9,97 |
|
Net income Million USD | Released Forecast Spread | -8,52 -8,80 3.17% | -7,33 -8,41 12.85% | -8,05 -7,92 -1.62% | -8,27 -8,09 -2.16% | -5,51 -8,53 35.49% | -6,40 -7,28 12.01% | -7,15 -9,00 20.61% | -7,70 -8,68 11.26% | -7,82 -8,88 11.88% | -8,90 | -9,80 | -10,5 | -10,9 |
|
EPS USD | Released Forecast Spread | -0,28 -0,25 -12% | -0,24 -0,28 12.73% | -0,14 -0,18 23.63% | -0,12 -0,11 -5.89% | -0,06 -0,09 33.33% | -0,06 -0,07 14.29% | -0,07 -0,09 22.22% | -0,08 -0,09 11.11% | -0,08 -0,09 11.11% | -0,09 | -0,10 | -0,10 | -0,10 |
| Announcement Date | 17/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 16/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 20/03/24 | - | - | - | - |
More events
Past sector events for Trevi Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TRVI Stock
- Calendar Trevi Therapeutics, Inc.
